Drugs / Varicella
Varicella
Regulatory milestones approvals, filings & regulatory actions · 1 recorded
| Milestone | Jurisdiction | Brand | Indication | Date | Sentence it was read from |
|---|---|---|---|---|---|
| Approved | EU (EMA) | ProQuad | — | 2006-04-05 | europa.eu ↗ |
Trials 3
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 31 trial | ||||||
| Phase 3 | NCT03205371 | Nov 2016 → Jul 2018 | meningococcal meningitis | Sanofi Pasteur, a Sanofi Company | Completed | No outcome recorded |
| Phase 42 trials | ||||||
| Phase 4 | NCT06038617 | Oct 2023 → Apr 2025 | — | Duke University | Completed | No outcome recorded |
| Phase 4 | NCT00329251 | Apr 2003 → Mar 2006 | HIV infectious disease | Hospital Clinic of Barcelona | Completed | No outcome recorded |
| Comparator or background therapy4 trials | ||||||
| Phase 2 | NCT00310856 Background | Jun 2005 → Nov 2006 | meningococcal meningitis | Novartis Vaccines | Completed | No outcome recorded |
| Phase 3 | NCT00806195 Background | Dec 2008 → Mar 2011 | meningitis, meningococcal infection | Novartis | Completed | No outcome recorded |
| Phase 3 | NCT00422292 Comparator | Dec 2006 → Jan 2009 | chickenpox, measles, meningococcal meningitis, mumps infectious disease +1 | Sanofi Pasteur, a Sanofi Company | Completed | No outcome recorded |
| Phase 4 | NCT00641446 Comparator | Oct 2001 → Oct 2003 | asthma | AstraZeneca | Completed | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 7 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Varicella | “Pneumococcal, DTaP, Haemophilus Influenzae Type B, MMR, Varicella, MMRV, Hepatitis A, Inactivated Poliovirus, Hepatitis B, Rotavirus, Influenza vaccines” NCT06038617 ↗ |
| Known as | Measles, Mumps, Rubella and Varicella | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00422292 ↗ |
| Known as | varicella zoster virus | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00641446 ↗ |
| Modality | Vaccine | “Measles, Mumps, Rubella, and Varicella (MMRV) vaccine” NCT00422292 ↗ |
| Route | Subcutaneous | “0.5 mL dose, SC” NCT00422292 ↗ |